[
  {
    "ref_criterion": "Uses all clinical references from the ADA 2024 Standard of Care.",
    "ref_axis": "instruction_following",
    "ref_point": 9,
    "gen_criterion": "Provides information on the official ADA guidelines for insulin therapy in gestational diabetes",
    "gen_axis": "accuracy",
    "gen_point": 5,
    "similarity": 0.4335,
    "point_diff": 4,
    "score": 0.347,
    "similar_match": false,
    "axis_match": false
  },
  {
    "ref_criterion": "Recommends that insulin should be used to manage type 1 diabetes and is the preferred agent for GDM and type 2 diabetes in pregnancy.",
    "ref_axis": "accuracy",
    "ref_point": 9,
    "gen_criterion": "Provides information on the official ADA guidelines for insulin therapy in gestational diabetes",
    "gen_axis": "accuracy",
    "gen_point": 5,
    "similarity": 0.6125,
    "point_diff": 4,
    "score": 0.49,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Recommends that either multiple daily injections or insulin pump technology can be used in pregnancy with type 1 diabetes.",
    "ref_axis": "accuracy",
    "ref_point": 9,
    "gen_criterion": "Provides information on the official ADA guidelines for insulin therapy in gestational diabetes",
    "gen_axis": "accuracy",
    "gen_point": 5,
    "similarity": 0.5892,
    "point_diff": 4,
    "score": 0.471,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "According to the ADA 2024 Standards of Care, target glycemic levels during pregnancy (including GDM) are: Fasting: \u226495 mg/dL (5.3 mmol/L), 1-hour postprandial: \u2264140 mg/dL (7.8 mmol/L), 2-hour postprandial: \u2264120 mg/dL (6.7 mmol/L).",
    "ref_axis": "accuracy",
    "ref_point": 8,
    "gen_criterion": "Does not provide a clear answer to the endocrinologist's question about glycemic targets and insulin dosing adjustment",
    "gen_axis": "completeness",
    "gen_point": -8,
    "similarity": 0.5472,
    "point_diff": 16,
    "score": 0.0,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Advises weight-based total daily dose (TDD) of insulin: 1st trimester: 0.7\u20130.8 units/kg/day, 2nd trimester: 0.8\u20131.0 units/kg/day, 3rd trimester: 0.9\u20131.2 units/kg/day.",
    "ref_axis": "accuracy",
    "ref_point": 8,
    "gen_criterion": "Provides information on the official ADA guidelines for insulin therapy in gestational diabetes",
    "gen_axis": "accuracy",
    "gen_point": 5,
    "similarity": 0.571,
    "point_diff": 3,
    "score": 0.571,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Starts with basal-bolus regimens for optimal control: Basal insulin (50%) using intermediate (NPH) or long-acting insulin (detemir), and bolus (prandial) insulin (50%) using rapid-acting insulin (e.g., insulin aspart, lispro) divided among meals.",
    "ref_axis": "accuracy",
    "ref_point": 8,
    "gen_criterion": "Provides information on the official ADA guidelines for insulin therapy in gestational diabetes",
    "gen_axis": "accuracy",
    "gen_point": 5,
    "similarity": 0.4657,
    "point_diff": 3,
    "score": 0.466,
    "similar_match": false,
    "axis_match": true
  },
  {
    "ref_criterion": "Evaluates and adjusts insulin requirements for individuals requiring insulin after delivery, since insulin resistance decreases in the postpartum period.",
    "ref_axis": "accuracy",
    "ref_point": 6,
    "gen_criterion": "Provides information on the official ADA guidelines for insulin therapy in gestational diabetes",
    "gen_axis": "accuracy",
    "gen_point": 5,
    "similarity": 0.6341,
    "point_diff": 1,
    "score": 0.634,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Recommends glucose monitoring frequency of four times daily (fasting and after meals), or sometimes more if glycemic control is labile.",
    "ref_axis": "accuracy",
    "ref_point": 6,
    "gen_criterion": "Does not provide a clear answer to the user's question about glycemic targets and insulin dosing adjustment",
    "gen_axis": "completeness",
    "gen_point": -8,
    "similarity": 0.4179,
    "point_diff": 14,
    "score": 0.0,
    "similar_match": false,
    "axis_match": false
  },
  {
    "ref_criterion": "Uses Metformin or Glyburide as first-line agents in GDM.",
    "ref_axis": "accuracy",
    "ref_point": -9,
    "gen_criterion": "Does not provide a clear answer to the user's question about glycemic targets and insulin dosing adjustment",
    "gen_axis": "completeness",
    "gen_point": -8,
    "similarity": 0.2423,
    "point_diff": 1,
    "score": 0.242,
    "similar_match": false,
    "axis_match": false
  }
]